These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study. Spunt SL; Million L; Chi YY; Anderson J; Tian J; Hibbitts E; Coffin C; McCarville MB; Randall RL; Parham DM; Black JO; Kao SC; Hayes-Jordan A; Wolden S; Laurie F; Speights R; Kawashima E; Skapek SX; Meyer W; Pappo AS; Hawkins DS Lancet Oncol; 2020 Jan; 21(1):145-161. PubMed ID: 31786124 [TBL] [Abstract][Full Text] [Related]
25. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577 [TBL] [Abstract][Full Text] [Related]
26. A comparison of staging systems for localized extremity soft tissue sarcoma. Wunder JS; Healey JH; Davis AM; Brennan MF Cancer; 2000 Jun; 88(12):2721-30. PubMed ID: 10870054 [TBL] [Abstract][Full Text] [Related]
27. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma. Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience. Fan P; Tao P; Wang Z; Wang J; Hou Y; Lu W; Ma L; Zhang Y; Tong H Front Oncol; 2024; 14():1373762. PubMed ID: 38601763 [TBL] [Abstract][Full Text] [Related]
31. New perspectives for staging and prognosis in soft tissue sarcoma. Lahat G; Tuvin D; Wei C; Anaya DA; Bekele BN; Lazar AJ; Pisters PW; Lev D; Pollock RE Ann Surg Oncol; 2008 Oct; 15(10):2739-48. PubMed ID: 18521685 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for survival of head and neck soft tissue sarcomas: A comparison between 7th and 8th edition AJCC staging systems. Ku JY; Roh JL; Cho KJ; Song JS; Choi SH; Nam SY; Kim SY Oral Oncol; 2020 Jul; 106():104705. PubMed ID: 32298997 [TBL] [Abstract][Full Text] [Related]
33. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015 [TBL] [Abstract][Full Text] [Related]
34. Overview of resistance to systemic therapy in patients with breast cancer. Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229 [TBL] [Abstract][Full Text] [Related]
35. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. Tanaka K; Mizusawa J; Naka N; Kawai A; Katagiri H; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Watanuki M; Yoshida Y; Okamoto T; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Ae K; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y BMC Cancer; 2019 Sep; 19(1):890. PubMed ID: 31492159 [TBL] [Abstract][Full Text] [Related]
36. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database. Cates JMM J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175 [No Abstract] [Full Text] [Related]
37. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481 [TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401 [TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Look Hong NJ; Hornicek FJ; Harmon DC; Choy E; Chen YL; Yoon SS; Nielsen GP; Szymonifka J; Yeap BY; DeLaney TF; Mullen JT Eur J Cancer; 2013 Mar; 49(4):875-83. PubMed ID: 23092789 [TBL] [Abstract][Full Text] [Related]
40. Validation of a Soft Tissue Sarcoma Nomogram Using a National Cancer Registry. Bagaria SP; Wagie AE; Gray RJ; Pockaj BA; Attia S; Habermann EB; Wasif N Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S398-403. PubMed ID: 26353762 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]